Prior to the oral therapy, what do we know about HCV-4 in Egypt: A randomized survey of prevalence and risks using data mining computed analysis

Medicine (United States)

Volumn 93, Issue 28, 2014, Pages e204-

  Aly Abd Elrazek, Abd Elrazek M ^a   Bilasy, Shymaa E ^b   Elbanna, Abduh E M ^c   Elsherif, Abd Elhalim A ^a  

^a Damietta Al Azhar university Hospital Cairo   (Egypt)

^b Suez Canal University   (Egypt)

^c Department of General Laparoscopic and Bariatric Surgery Al Husain University Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; DATA MINING; DIGESTIVE TRACT PARAMETERS; DISEASE SEVERITY; ECHOGRAPHY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL WALL THICKNESS; ESOPHAGUS VARICES; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 4; HEPATITIS C VIRUS GENOTYPE 4 INFECTION; HUMAN; INFECTION RATE; INFECTION RISK; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; SEX RATIO;

EID: 84920202277     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000204     Document Type: Article

References (41)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HCV seroprevalence. Hepatology. 2013; 57: 1333-1342.
2. Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol. 2001; 82: 693-712.
3. El-Shamy A, Hotta H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview. World J Gastroenterol. 2014; 20: 7555-7569.
4. Rouabhia S, Sadelaoud M, Chaabna-Mokrane K, et al. Hepatitis C virus genotypes in north eastern Algeria: a retrospective study. World J Hepatol. 2013; 5: 393-397.
5. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013; 10: 553-562.
6. El-Zayadi AR, Badran HM, Barakat EM, et al. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol. 2005; 11: 5193-5198.
7. Asselah T. Sofosbuvir for the treatment of hepatitis C virus. Expert Opin Pharmacother. 2014; 15: 121-130.
8. Lu S, Jin B, Cowart LA, Lu X. From data towards knowledge: revealing the architecture of signaling systems by unifying knowledge mining and data mining of systematic perturbation data. PLoS ONE. 2013; 8: e61134.
9. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology. 1997; 26: 521-526.
10. Swain MG, Lai MY, Shiffman ML, et al. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. Gastroenterology. 2010; 139: 1593-1601.
11. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006; 13: 34-41.
12. Agha S, El-Mashad N, El-Malky M, et al. Prevalence of low positive anti-HCV antibodies in blood donors: schistosoma mansoni coinfection and possible role of autoantibodies. Microbiol Immunol. 2006; 50: 447-452.
13. Guerra J, Garenne M, Mohamed MK, Fontante A. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat. 2012; 19: 560-567.
14. Mohamed MK. Epidemiology of HCV in Egypt 2004. Afro-Arab Liver J. 2004; 13: 41-52.
15. Mohamoud YA, Mumtaz GR, Riome S, et al. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013; 13: 288.
16. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology. 2001; 13: 248-253.
17. Hayashida K, Shoji I, Deng L, et al. 17b-Estradiol inhibits the production of infectious particles of hepatitis C virus. Microbiol Immunol. 2010; 54: 684-690.
18. Tang S, Yue M, Wang J, et al. Association of genetic variants in estrogen receptor a with HCV infection susceptibility and viral clearance in a high-risk Chinese population. Eur J Clin Microbiol Infect Dis. 2014; 33: 999-1010.
19. Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int. 2003; 23: 63-69.
20. Poynard T, Ratziu V, Charlotte F, et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol. 2001; 34: 730-739.
21. Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res. 2007; 37: 239-247.
22. Ramachandran P, Fraser A, Agarwal K, et al. UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther. 2012; 35: 647-662.
23. Ghany MG, Nelson DR, Strader DB, et al. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011; 54: 1433-1444.
24. El-Shamy A, Shoji I, El-Akel W, et al. NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients. J Clin Microbiol. 2012; 50: 3886-3892.
25. Asselah T, De Muynck S, Broët P, et al. IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C. J Hepatol. 2012; 56: 527-532.
26. De Nicola S, Aghemo A, Rumi MG, et al. Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4. Hepatology. 2012; 55: 336-342.
27. Abdel-Rahman M, El-Sayed M, El Raziky M, et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World J Gastroenterol. 2013; 19: 2691-2696.
28. Razek Abd El, Mahfouz Hamdy M, Afifi M, et al. Detection of risky esophageal varices by two-dimensional ultrasound: when to perform endoscopy. Am J Med Sci. 2014; 347: 28.
29. Ali Abd Elrazek AEM, Abd Elazeem K, El sherif AEA, El sherbiny S, Abdel-aal UM, Bilasy SE. Screening esophagus during routine U/S: medical and cost benefits. Eur J Gastroenterol Hepatol 2014, [Epub ahead of print].
30. Kamal S, Madwar M, Bianchi L, et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver. 2000; 20: 281-289.
31. Carbonell AM, Wolfe LG, DeMaria EJ. Poor outcomes in cirrhosisassociated hernia repair: a nationwide cohort study of 32, 033 patients. Hernia. 2005; 9: 353.
32. Marsman HA, Heisterkamp J, Halm JA, et al. Management in patients with liver cirrhosis and an umbilical hernia. Surgery. 2007; 142: 372.
33. Triantos CK, Kehagias I, Nikolopoulou V, Burroughs AK. Surgical repair of umbilical hernias in cirrhosis with ascites. Am J Med Sci. 2011; 341: 222-226.
34. Sarit C, Eliezer A, Mizrahi S. Minimally invasive repair of recurrent strangulated umbilical hernia in cirrhotic patient with refractory ascites. Liver Transplant. 2003; 9: 621.
35. Melcher ML, Lobato RL, Wren SM. A novel technique to treat ruptured umbilical hernias in patients with liver cirrhosis and severe ascites. J Laparoendosc Adv Surg Tech A. 2003; 13: 331.
36. Senzolo M, Cholongitas E, Tibballs J, et al. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome. Eur J Gastroenterol Hepatol. 2006; 18: 1143-1150.
37. Belli G, D'Agostino A, Fantini C, et al. Laparoscopic incisional and umbilical hernia repair in cirrhotic patients. Surg Laparosc Endosc Percutan Tech. 2006; 16: 330.
38. North M. Data mining for the masses.USA Global Text Project, Aug; 2012; ISBN 0615684378, 9780615684376.
39. Abd Elrazek AE, Mahfouz HM, Metwally A, El-Shamy A. Mortality prediction of non-alcoholic patients presenting with upper gastrointestinal bleeding using data mining. Eur J Gastroenterol Hepatol. 2014; 26: 187.
40. Aly abd Elrazek Abd Elrazek M, Mahfouz HM. Prediction analysis of esophageal variceal degrees using data mining: is validated in clinical medicine? Global J Comput Sci Technol. 2013; 13: 1-5.
41. Elbanna A, Elrazek A. Is advanced statistical computing technology a clue in applied medicine? A study using data mining as a predictor technology in gastroenterology & bariatric surgery; novel elbanna operations. Global J Comput Sci Technol. 2013; 13: 31-37.